ST. LOUIS (KTVI) – Monoclonal antibody treatments received a thumbs up from a study by the Mayo Clinic released Monday. The study suggests the treatment can help those who are at high risk of serious ...
The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...
With omicron’s explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options that will stand up to the variant. The first oral antiviral treatment for the ...
COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health ...
Pediatrician Dr. Sophie Katz explains how to prepare for RSV season, including vaccination and other prevention tips.
Following Phase 3 trials, the drug candidate manufacturer can apply for a New Drug Application (NDA) from the FDA. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results